UKHSA In silico modelling of the Nucleocapsid protein of SARS-CoV-2

Market Engagement - In silico analysis of the impact of mutations of the Nucleocapsid protein of SARS-CoV-2 on lateral flow device sensitivity. Atamis project reference: C103586 The UK Health Security Agency (UKHSA) wishes to inform the market of a potential future procurement to source a suitably qualified supplier (or an optimal combination of suppliers) to develop an in-silico protein model that can analyse the impact of mutations of the Nucleocapsid protein structure of SARS-CoV-2 and its subsequent impact on l...